CPRX vs UPST · P/E 18, rev $491.7M vs P/E 74, rev $672.9M
Catalyst Pharmaceuticals Inc (CPRX) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
CPRX currently screens at market cap $3.84B and trailing P/E 18.2. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the CPRX and UPST stock pages for the full models.
Not investment advice.